We have signed an MOU with Abnova for joint antibody development and supply, enabling us to analyze all CD markers upon completion of equipment development.

On April 22, 2019, Abnova CEO Wilber Huang and Vice President Hsien Chen visited us and signed a memorandum of understanding for joint collaboration in new product development.

This agreement is expected to further enhance the synergy between the two companies' accumulated expertise.